Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

Philippe Gevaert(Ghent University), Lien Calus(Ghent University Hospital), Thibaut Van Zele(Ghent University Hospital), Katrien Blomme(Ghent University Hospital), Natalie De Ruyck(Ghent University Hospital), Wouter Bauters(Ghent University Hospital), Peter W. Hellings(KU Leuven), Guy Brusselle(Ghent University Hospital), Dirk De Bacquer(Ghent University), Paul Van Cauwenberge(Ghent University Hospital), Claus Bachert(Ghent University Hospital)

Journal of Allergy and Clinical Immunology

September 26, 2012

10.1016/j.jaci.2012.07.047

Cited by 742

Abstract

Related Papers

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne|PubMed|1992|34k

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels|Arerugī/Arerugi|1996|10.1k

Staging in rhinosinusitus.

V J Lund, I S Mackay|PubMed|1993|1.5k

Down-regulation of Fc(ε)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody

Donald W. MacGlashan, Bruce S. Bochner, D C Adelman et al.|The Journal of Immunology|1997|822

Total and specific IgE in nasal polyps is related to local eosinophilic inflammation

Claus Bachert, Philippe Gevaert, Gabriële Holtappels et al.|Journal of Allergy and Clinical Immunology|2001|694